WASHINGTON/NEW YORK The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis. | Video
- WHO expects more Ebola cases in Congo, can't reach no-go areas
- World's top pork firm shuts China slaughterhouse in race to contain deadly swine fever
- China sacks top official over vaccine scandal, firm may de-list
- FDA approves Teva's generic of Mylan's EpiPen
- Illness at Ohio Chipotle caused by food-borne bacteria: local officials
LONDON Vaping rules should be relaxed to allow the promotion of e-cigarettes as tools to help tobacco smokers quit, British lawmakers said on Friday.
FRANKFURT Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.
Japan's Eisai Co Ltd said on Thursday it would price its cancer drug Lenvima at about $16,000 for a month's supply before discounts, after the U.S. Food and Drug Administration approved its use in patients with a common form of liver cancer.
NEW YORK/BOSTON OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its potential liabilities swell with a wave of lawsuits over the opioid addiction epidemic sweeping the United States, people familiar with the matter said on Thursday.